Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...
We wouldn’t allow a new drug to be sold without thorough testing for safety and efficacy, so why should AI be any different?
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
A growing body of research shows that exposure can increase the risk of prostate, kidney and testicular cancers. The ...
A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...
Arsenic — a naturally occurring compound that elevates the risk of skin, lung, and bladder cancer, among a host of other health issues — has recently been contaminating food products, causing some ...
Her expertise is in personal finance and investing, and real estate. The Food and Drug Administration (FDA) is a government agency that is responsible for the promotion and protection of public ...
Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults ...
The Food and Drug Administration continues using import alerts to enforce U.S. food safety regulations for food from foreign ...